• MillNest Originals
  • MillNest Academy
  • Machine Selector Tool

Pharmaceuticals

Pharmaceutical powder processing is defined by what cannot be compromised — particle size specification that directly affects dissolution and bioavailability, contained handling that protects the operator from potent actives, GMP-compliant construction that withstands validated cleaning between every product, and batch documentation that proves every step was done correctly. MillNest builds powder processing equipment to these standards without the overhead of a full pharmaceutical OEM — and validates performance before handover.
DISCUSS YOUR REQUIREMENT
All Process Solutions

GMP-compliant SS 316 construction

Contained API handling

Validated cleaning & batch records

Materials We Process
Products from this industry we handle

Active Pharmaceutical Ingredients (API)

Lactose & Excipients

Microcrystalline Cellulose

Starch USP & Modified

Herbal API & Botanical Extracts

Talc & Magnesium Stearate

HPMC & Polymers

COMMON PROCESSING CHALLENGES
Where things go wrong

Most of these are avoidable if the equipment is selected with the right material data. They become expensive when they surface after commissioning.

Particle size that drifts during a production run affects how the active ingredient dissolves in the body — a tablet that looks correct can still fail dissolution testing.

Active ingredients added at very small quantities to a large batch are the most common source of blend uniformity failure — the tablet at one end of the compression run contains a different dose than the tablet at the other end.

Running multiple product grades on the same machine without proper cleaning leaves traces of the previous product in the next batch.

Residue left in mill or blender dead zones from a previous product batch contaminates the next — in pharmaceutical manufacturing this is a regulatory failure, not just a quality issue.

Fine pharmaceutical powders generate dust at every transfer point — in a GMP facility, airborne powder is a containment failure, a yield loss and an operator safety issue simultaneously.

Over-milling an active ingredient reduces particle size below the target range and changes how it behaves during compression — tablets crack, cap or fail hardness testing as a result.

Granules that are too dry become brittle during compression — tablets formed from over-dried granules fail friability testing and generate excessive fines on the production line.

Cleaning validation on shared pharmaceutical equipment requires documented proof that no residue from the previous product remains — equipment with poor access for inspection cannot be validated and cannot be used.

Process Solutions & Equipment
How MillNest addresses this sector

Each row below pairs a process solution with the specific equipment used in pharmaceutical powder applications. Click either side to go deeper.

API & Excipient Milling

Specification-holding size reduction for pharmaceutical powders

Pharmaceutical milling is specification-driven in a way that other industries are not — the particle size distribution is a validated parameter, not a quality target. The MACM is the standard equipment choice for API size reduction where D90 or D97 must be held within specification across a full campaign: the integrated classifier recirculates oversize material until specification is met, eliminating screen changes and the specification drift that accompanies them. For excipient milling and dry granule sizing, the universal mill offers multi-mode flexibility with GMP-compliant SS 316 construction and validated cleaning capability.

Explore Solution
Equipment used in this application
MHAM

Hammer Mill

Primary prill and granule size reduction — abrasion-resistant configurations for hard mineral grades

MACM

Air Classifying Mill

Fine powder for water-soluble grades — D90 control, prevents heat build-up on sensitive salts

Pharmaceutical Blending

GMP blending with RSD <5% uniformity at dosage unit level

Pharmaceutical blending for oral solid dosage forms requires blend uniformity at the dosage unit level — typically RSD <5% — not batch-level homogeneity. For formulations where the API is present at low concentrations (1–5%), achieving this standard requires the blender selection, fill ratio, rotation speed and blend time to be validated for the specific formulation. MillNest supplies ribbon and paddle blenders in GMP-compliant SS 316 construction with Ra ≤ 0.8 µm internal surface finish, full-drain design, validation documentation support and cleaning procedure development as part of the project scope.
Explore Solution
Equipment used in this application
MBRL

Ribbon Blender

Double-helical ribbon handles density variation across the full batch — standard choice for dry NPK mixing

MPBL

Paddle / Plough Blender

Where ribbon action doesn't achieve uniformity — denser, cohesive or difficult-to-blend formulations

Contained Handling & Transfer

Operator protection at every potent API handling stage

Potent API handling requires containment at every point where the powder is exposed — mill inlet, mill outlet, transfer to blender, intermediate bin discharge. The containment requirement is defined by the API’s occupational exposure limit (OEL) and the quantities involved. MillNest designs contained transfer systems — closed mill discharge with glove ports, contained bin-to-bin transfer, local exhaust ventilation at exposure points — specific to the OEL of the material being processed. Dust capture at all generation points uses SS 316 cyclone-bag filter systems configured for the specific material’s particle characteristics.

Explore Solution
Equipment used in this application
MLUM

Delumper

Gentle lump breaking on caked hygroscopic powders — restores flow without changing the powder spec

Weighing & Batch Documentation

GMP-compliant dosing with electronic batch records

Pharmaceutical batch manufacturing records are not optional documentation — they are the regulatory evidence that every material was added at the correct quantity, in the correct sequence, by an identified operator, at a recorded time. Electronic batch recording at the weighing station, with operator verification and supervisor review capability, is the correct implementation for GMP compliance. Micro-dosing stations for potent active additions provide ±1g resolution with contained addition points, slow-feed auger control and dose verification before proceeding to the next ingredient — the standard expected in Schedule M compliant Indian pharmaceutical facilities and WHO-GMP audited export operations.
Explore Solution
Equipment used in this application
SCRW

Screw Conveyor

Sealed horizontal and inclined transfer for hygroscopic and abrasive fertilizer powders

CYCL / BAG

Cyclone + Bag Filter

Dust capture and product recovery at milling, transfer and packing points

Tell us about your pharmaceutical powder application.
We'll design to your GMP requirement.

Share the API, its OEL category, particle size specification, blending standard and GMP compliance requirement. MillNest will design the right equipment configuration — validated before handover.
DISCUSS YOUR REQUIREMENT
Talk to an Engineer